Viewing Study NCT00169195

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:03 PM
Ignite Modification Date: 2026-02-26 @ 8:11 PM
Study NCT ID: NCT00169195
Status: COMPLETED
Last Update Posted: 2015-09-02
First Post: 2005-09-12
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Rituximab, Gemcitabine and Oxaliplatin (R-GEMOX) for Refractory/Relapsed B-cell Lymphoma
Sponsor: Lymphoma Study Association
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diffuse Large Cell Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None B-cell lymphoma View
None Salvage Therapy View
None rituximab View
None oxaliplatine View
None gemcitabine View